These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2230339)

  • 1. Phase-contrast study of the efficacy of Lampit (BAY 2502, Nifurtimox) on experimental infection with Trypanosoma rhodesiense.
    Soliman MA
    J Egypt Soc Parasitol; 1990 Dec; 20(2):821-6. PubMed ID: 2230339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
    Nwodo NJ; Brun R; Osadebe PO
    J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of choroid plexus involvement in chronic infections of mice with Trypanosoma brucei gambiense.
    Van Marck EA; Mulumba P; Beckers A; Gigase P; Wéry M
    Contrib Microbiol Immunol; 1983; 7():173-82. PubMed ID: 6825438
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of dipalmitoylphosphatidylcholine liposome against African trypanosomes.
    Kuboki N; Yokoyama N; Kojima N; Sakurai T; Inoue N; Sugimoto C
    J Parasitol; 2006 Apr; 92(2):389-93. PubMed ID: 16729700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nifurtimox on experimental infections with trypanosomatidae other than Trypanosoma cruzi.
    Haberkorn A
    Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):331-8. PubMed ID: 506553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the effects of some game animal tranquillising drugs on Trypanosoma brucei rhodesiense infections in white rats.
    Rickman LR; Rottcher D
    East Afr Med J; 1980 May; 57(5):327-31. PubMed ID: 7398548
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of the infectivity of T.b. rhodesiense isolates from man to 3 species of small laboratory rodents.
    Rickman R; Kanyangala S
    East Afr Med J; 1990 Jun; 67(6):413-8. PubMed ID: 2279470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of nifurtimox in human African trypanosomiasis].
    Moens F; De Wilde M; Ngato K
    Ann Soc Belg Med Trop; 1984 Mar; 64(1):37-43. PubMed ID: 6732304
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of some African game animal sera on Trypanosoma brucei rhodesiense and T.b. brucei clones.
    Rickman L; Kolala F
    Tropenmed Parasitol; 1982 Jun; 33(2):129-35. PubMed ID: 7051497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
    Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
    Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
    J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
    Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
    Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rational concepts and the study of active molecules against various trypanosomiases].
    Périé J; de Albuquerque C; Blonski C; Chauvière G; Gefflaut T; Page P; Trinquier M; Willson M
    Bull Soc Pathol Exot; 1994; 87(5):353-61. PubMed ID: 7496200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on difluoromethylornithine in African trypanosomes.
    McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
    Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of Trypanosoma brucei, T. rhodesiense, and T. gambiense by the indirect fluorescent antibody test.
    Latif BM; Adam KM
    Bull World Health Organ; 1973; 48(4):401-7. PubMed ID: 4587481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of Ro 15-0216 against human strains of Trypanosoma gambiense maintained in rodents. A preliminary study].
    Richard-Lenoble D; Kombila MY; Felix H
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):609-15. PubMed ID: 3197254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of methionine transport and metabolism by Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
    Goldberg B; Rattendi D; Lloyd D; Yarlett N; Bacchi CJ
    Arch Biochem Biophys; 2000 May; 377(1):49-57. PubMed ID: 10775440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.